rs863225243
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_005219.5(DIAPH1):c.3145C>T(p.Arg1049Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005219.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIAPH1 | NM_005219.5 | c.3145C>T | p.Arg1049Ter | stop_gained | 23/28 | ENST00000389054.8 | NP_005210.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DIAPH1 | ENST00000389054.8 | c.3145C>T | p.Arg1049Ter | stop_gained | 23/28 | 5 | NM_005219.5 | ENSP00000373706 | A2 | |
DIAPH1 | ENST00000518047.5 | c.3118C>T | p.Arg1040Ter | stop_gained | 22/27 | 5 | ENSP00000428268 | P4 | ||
DIAPH1 | ENST00000647433.1 | c.3145C>T | p.Arg1049Ter | stop_gained | 23/29 | ENSP00000494675 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461858Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727228
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 03, 2016 | The R1049X pathogenic variant in the DIAPH1 gene has been reported in the homozygous state in association with syndromic microcephaly including seizures, developmental delay, vision loss, and facial dysmorphism (Yavarna et al., 2015; Al-Maawali et al., 2016). In addition, the R1049X variant was reported in an abstract by Kim et al. (2014) in the heterozygous state as co-segregating with a dominant form of hearing loss in a single family. The R1049X variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. This variant was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret R1049X as a pathogenic variant. - |
Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 13, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at